Related Experiment Video

Updated: Jul 15, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

[Blockage of U251 cells in G0/G1 through MAPK signaling pathway by LRRC4]

Ming-Hua Wu1, Chen Huang, Xiao-Ling Li

  • 1Cancer Research Institute, Central South University, Changsha, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|May 5, 2007
PubMed
Abstract

Insights

LRRC4, a glioma suppressive gene, blocks U251 cells in G0/G1 by modulating the MAPK pathway. This involves regulating JNK2, phosphorylated c-Jun, mutant P53, and cyclin D1 expression, offering potential therapeutic insights.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • LRRC4 is recognized as a glioma suppressive gene.
  • The MAPK signaling pathway plays a crucial role in cell cycle regulation.
  • U251 cells are a commonly used human glioblastoma cell line.

Purpose of the Study:

  • To investigate the impact of LRRC4 on U251 cell cycle progression.
  • To elucidate the role of the MAPK signaling pathway in LRRC4-mediated cell cycle arrest.
  • To determine the specific molecular targets of LRRC4 within the MAPK pathway.

Main Methods:

  • LRRC4 gene transfection into U251 cells to establish stable clones.
  • Analysis of MAPK pathway components (ERK, JNK, P38) using Western blot.
  • Cell cycle analysis via FACS, and assessment of cyclin D1 using Luciferase reporter gene assay and Western blot.

Main Results:

  • LRRC4 transfection altered MAPK pathway signaling, down-regulating phosphorylated ERK2 and up-regulating total JNK2 and phosphorylated c-Jun.
  • LRRC4 expression led to decreased levels of mutant P53 and reduced cyclin D1 activation and expression.
  • U251 cells exhibited a significant block in the G0/G1 phase of the cell cycle.

Conclusions:

  • LRRC4 effectively induces G0/G1 cell cycle arrest in U251 cells.
  • The mechanism involves modulation of the MAPK pathway, specifically affecting JNK2, phosphorylated c-Jun, mutant P53, and cyclin D1.
  • LRRC4 demonstrates potential as a therapeutic agent for glioma by controlling cell proliferation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...